Additional possibilities of antihypertensive therapy for metabolic syndrome
Metabolic syndrome (MS) is a clinical and laboratory symptom complex that encompasses abdominal obesity, carbohydrate and fat metabolic disturbances, arterial hypertension (AH), and target organ involvement. The drugs of first choice in the management of patients with AH and MS are renin-angiotensin...
Main Authors: | O A Kislyak, M V Pokhilchenko |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Morozov P.V.
2013-06-01
|
Series: | Системные гипертензии |
Subjects: | |
Online Access: | https://syst-hypertension.ru/2075-082X/article/view/28965 |
Similar Items
-
Possibilities of rational combination antihypertensive therapy: Results of HEMERA international clinical trial
by: I E Chazova, et al.
Published: (2013-10-01) -
TRIPLE ANTIHYPERTENSIVE THERAPY: FOCUS ON EFFICACY AND PROGNOSIS
by: O. D. Ostroumova, et al.
Published: (2018-07-01) -
From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift
by: O D Ostroumova, et al.
Published: (2015-12-01) -
Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study
by: Hong SJ, et al.
Published: (2020-12-01) -
MODERN POSSIBILITIES OF ACHIEVING TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS IN OUTPATIENT PRACTICE: THE LEADER STUDY RESULTS
by: D. V. Nebieridze, et al.
Published: (2018-03-01)